亚辉龙

Weihnachten steht vor der Tür. Wir wünschen Ihnen viel Erfolg und Gesundheit im kommenden Jahr. 🎄 Frohe Weihnachten und Guten Rutsch ins Neujahr!

🎄 The countdown to Christmas is on! Let YHLO iFlash series bring some holiday magic to your lab, making testing efficient so you can focus on what truly matters. 🎥 Watch the video to see how we make diagnostics effortless. Test Made Easy, Free to Be Merry—helping labs around the world deliver fast & accurate results, and celebrate the holiday with joy. #YHLO #iFlash #CLIA #IVD #TestMadeEasy #Diagnostics #MerryChristmas

YHLO High-Performance Immunoassay Rapid Detection System Achieves Key Milestones! YHLO has made significant progress in the development of its high-performance immunoassay rapid detection system, part of China’s 14th Five-Year Plan for R&D in diagnostic and therapeutic equipment. Launched in December 2023, this project aims to improve cardiovascular disease prevention and management globally. 🔑 Key Milestone: HARBOR Study A key breakthrough is the HARBOR Study, China’s largest multi-center research on cardiovascular biomarker reference ranges in healthy populations. The study covers various regions across China and establishes reference values for hs-cTnI testing, including age- and gender-specific data. Over 20 leading cardiovascular hospitals have joined the study, with plans to expand further. At a recent conference, Prof. Lin Yahui from Fuwai Hospital presented the first batch of HARBOR study data, highlighting that YHLO's hs-cTnI test achieved over 98% detection sensitivity above the limit of detection (LoD). This data marks a significant milestone and will contribute to optimizing clinical pathways for cardiovascular emergencies, providing a solid foundation for future clinical practice.

On December 7th, together with our partner, we hosted an academic conference in Uzbekistan, bringing together 3 Chinese and 6 Uzbek KOLs to share valuable insights on autoimmune diseases, APS diagnosis, liver health, and gold-standard cardiac diagnostics, including hs-cTnI, NT-proBNP, and D-Dimer.

Three new assays are now available: IL-6, 17-OHP, and NT-proBNP, further expanding our diagnostic capabilities in inflammation, reproductive health, and cardiac health. #YHLO #Diagnostics #Inflammation #ReproductiveHealth #CardiacHealth #IL6 #17OHP #NTproBNP #IVD #CLIA

🌟 Empowering Global Partners 🌍 Engineers from Qatar and Indonesia recently visited YHLO for exclusive training, followed by a tour of the factory and exhibition hall. Watch the documentary to see how we’re strengthening global partnerships and driving innovation in diagnostics. #YHLO #Engineering #Training #PartnerCollaboration #FactoryTour #Documentary #Video #Interview

YHLO has been ranked among the top 20 IVD companies in the 2024 China Medical Device R&D Strength Rankings! This achievement highlights our commitment to innovation and excellence in the IVD field. With over 176 product registrations globally and 237 granted patents, we continue to push the boundaries of medical diagnostics. We’re proud of our team's hard work and looking forward to making an even bigger impact on global health! #Innovation #Healthcare #IVD #YHLO #MedicalDevices #Diagnostics #CLIA #Immunoassay #Biochemistry

🍂🥧 Happy Thanksgiving from YHLO! 🥧🍂 As we embrace this season of gratitude, all of us at YHLO want to reflect on the relationships and milestones that have shaped our journey. Whether you are a trusted partner, a valued customer, or a dedicated colleague, your support and collaboration have been key to our shared success. Wishing you a Thanksgiving filled with warmth, joy, and meaningful moments. 🦃 #YHLO #Thanksgiving #Joy #Grateful

Today, we shipped the first iBC 900 Biochemistry Analyzer to the international market. This marks the beginning of our journey🚀. We’re excited for what’s ahead and confident that this is just the start of many more milestones.

✨🔗 Integrated Excellence: iBC 900 + iFlash 3000 iBC 900 Biochemistry Analyzer can be seamlessly integrated with iFlash 3000 Immunoassay analyzer, offering an all-in-one Immunoassay-Biochemistry solution to optimize your laboratory operations. Features of iBC 900 + iFlash 3000 integration: 💠 One-step solution: One-stop work, Simplify workflow, Reduce workload 💠 High-throughput: Minimize TAT (Turnaround Time) for faster results 💠 Flexible configurations: Tailored for diverse testing needs This powerful integration enhances efficiency, ensures reliable performance, and supports better patient care. Ready to streamline your lab with YHLO’s innovative solutions? #iBC900 #iFlash3000 #YHLO #LaboratoryAutomation #DiagnosticsInnovation #BiochemistryAnalyzer #CLIAAnalyzer #Diagnostics #IVD #Immunoassay